医学
药效学
兴奋剂
药代动力学
药理学
受体
糖尿病
胰高血糖素样肽1受体
内科学
内分泌学
作者
Yang Zou,Fan Jiang,Chan Sun,Chunyang Zhao,Hongjie Qian,Jingying Jia,Chen Yu,Hong Chen,Mingli Wang,Qian Chen
摘要
This study aimed to assess the safety, pharmacokinetics and pharmacodynamics of noiiglutide (SHR20004), a novel glucagon-like peptide-1 receptor agonist, in Chinese obese participants without diabetes mellitus (DM).
科研通智能强力驱动
Strongly Powered by AbleSci AI